Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study

Journal of Perinatology volume 29, pages 297–304 (2009)Cite this article

Abstract

Objective:

As effects of glucocorticoids differ with respect to preparation, dose and duration, we hypothesized that a postnatal regimen of a low-dose, short-course betamethasone treatment had comparable efficacy and a better safety profile compared to the conventional high-dose, dexamethasone.

Study Design:

To test our hypothesis, we selected premature neonates with a birth weight⩽1000 g and a gestational age ⩽29 weeks who were ventilated >10 postnatal days with an FiO2>0.4 and no ability to wean mechanical support for ⩾3 consecutive days. These neonates either received twice daily dexamethasone 0.25 mg kg−1 per dose intravenously for 3 days tapered to 0.125 mg kg−1 per dose for 4 days (June 1999 to December 2000) or betamethasone 0.125 mg kg−1 per day intramuscularly once per day for 3 days (January 2001 to December 2002).

Result:

We found a significant reduction in FiO2 after 3 days in both glucocorticoid treatment groups. There were no significant differences between the two treatment groups in the clinical parameters including decrease in FiO2, oxygenation index, mean airway pressure and percent extubation. Duration of ventilation, number of oxygen days and length of hospital stay were comparable in the two groups. Of particular interest, the betamethasone group showed fewer adverse effects, such as poor weight gain and high blood glucose, than the dexamethasone group.

Conclusion:

A short course of low-dose betamethasone has comparable efficacy and seemingly a better short-term safety profile compared to conventional dexamethasone treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP . Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluid of high risk preterm neonates. Pediatrics 1994; 93: 712–718.

    CAS  Google Scholar 

  2. Pierce MR, Bancalari E . The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995; 19: 371–378.

    Article  CAS  Google Scholar 

  3. Halliday HL, Ehrenkranz RA, Doyle LW . Delayed (>3 Weeks) Postnatal Corticosteroids for Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.

  4. Halliday HL, Ehrenkranz RA, Doyle LW . Moderately Early (7–14 Days) Postnatal Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.

  5. Halliday HL, Ehrenkranz RA, Doyle LW . Early Postnatal (<96 Hours) Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.

  6. Grier DG, Halliday HL . Management of BPD: guidelines for corticosteroid use. Drugs 2005; 66 (1): 15–29.

    Article  Google Scholar 

  7. American Academy of Pediatrics, Committee on Fetus and Newborn and Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330–338.

    Article  Google Scholar 

  8. Taylor C, Shah P, Dunn M . Meta-analysis of postnatal steroid use challenged. Pediatrics 2002; 109: 716–717.

    Article  Google Scholar 

  9. Jacobs HC, Chapman RL, Gross I . Premature conclusions on postnatal steroid effects. Pediatrics 2002; 110: 200–201.

    Article  Google Scholar 

  10. Soll RF . Corticosteroids for the treatment & prevention of BPD. Acta Paediatr 2003; 92: 886–889.

    Article  Google Scholar 

  11. Ruffert P, Pmpana JP, Breart G, Saugstad OD, Goelz R, Halliday HL et al. Treatment strategies for BPD with postnatal corticosteroids in Europe: the EURAIL survey. Acta Paediatr 2003; 92: 948–951.

    Article  Google Scholar 

  12. Jobe AH . Glucocorticoids, inflammation and the perinatal lung. Semin Neonatol 2001; 6: 331–342.

    Article  CAS  Google Scholar 

  13. Mathews SG . Antenatal glucocorticoids and the developing brain: mechanisms of action. Semin Neonatol 2001; 6: 309–317.

    Article  Google Scholar 

  14. Whitelaw A, Thoresen M . Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 2000; 83: F154–F157.

    Article  CAS  Google Scholar 

  15. Abraham I, Harkany T, Hovath KM, Veenema AH, Penke B, Nyakas C et al. Chronic corticosterone administration dose dependency modulates Aβ(1-42) and NMDA induced neurodegeneration in rat magnocellular nucleus basalis. J Neuroendocrinol 2000; 12: 486–494.

    Article  CAS  Google Scholar 

  16. Baud O, Fiox-L’Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 341: 1190–1196.

    Article  CAS  Google Scholar 

  17. Trenque T, Lamiable D, Vistelle R, Millart H, Leterre A, Choisy H . Comparative pharmacokinetics of two diasteroisomers dexamethasone and betamethasone in plasma and cerebrospinal fluid in rabbits. Fundam Clin Pharmacol 1994; 8: 430–436.

    Article  CAS  Google Scholar 

  18. Alderson AL, Novack TA . Neurophysiological and clinical aspects of glucocorticoids and memory: a review. J Clin Exp Neuropsychol 2002; 24: 335–355.

    Article  Google Scholar 

  19. Christensen HD, Sienko AE, Rayburn WF, Gonzalez CL, Coleman FH . A placebo controlled, blinded comparison between betamethasone and dexamethasone to enhance lung maturation in fetal mouse. J Soc Gynecol Invest 1997; 4: 130–134.

    Article  CAS  Google Scholar 

  20. Löhle M, Müller T, Wicher C, Roedel M, Schubert H, Witte OW et al. Betamethasone effects on fetal sheep cerebral blood flow are not dependent on maturation of cerebrovascular system and pituitary–adrenal axis. J Physiol 2005; 564 (Part 2): 575–588.

    Article  Google Scholar 

  21. Cambonie G, Mesnage R, Milési C, Pidoux O, Veyrec C, Picaud JC . Betamethasone impairs cerebral blood flow velocities in very premature infants with severe chronic lung disease. J Pediatr 2008; 152 (2): 270–275.

    Article  CAS  Google Scholar 

  22. La Gamma EF, Browne LE . Feeding practices for infants weighing less than 1500 g at birth and the pathogenesis of necrotizing enterocolitis. Clinics Perinatol 1994; 21: 271–306.

    Article  CAS  Google Scholar 

  23. Brumberg H, La Gamma EF . Nutrition: enhance outcomes for premature infants. Pediatr Ann 2003; 32 (9): 617–625.

    Article  Google Scholar 

  24. Mishra R, Golombek SG, Ramirez-Tolentino SR, Das S, La Gamma EF . Low-birth-weight neonates exhibit a physiological set-point to regulate CO2: an untapped potential to minimize volutrauma-associated lung injury. Am J Perinatol 2003; 20: 453–463.

    Article  Google Scholar 

  25. Zia M, Mishra R, Hassan M, LaGamma EF . Optimal FRC approach to hyaline membrane disease and its effects on chronic lung disease. Pediatr Res 2002; 51940: 2279A.

    Google Scholar 

  26. Durand M, Mendoza ME, Tantivit P, Kugelman A, McEvoy C . A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation. Pediatrics 2002; 109: 262–268.

    Article  Google Scholar 

  27. Charles B, Schild P, Steer P, Cartwright D, Donovan T . Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants. Dev Pharmacol Ther 1993; 20: 205–210.

    Article  CAS  Google Scholar 

  28. Ballard PL, Ballard RA . Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173: 254–262.

    Article  CAS  Google Scholar 

  29. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ et al. Very low birth weight outcomes of National Institutes of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001; 107, Available at: http://www.pediatrics.org/cgi/content/full/107/1/e1.

  30. Baraldi E, Filippone M . Chronic lung disease after premature birth. N Engl J Med 2007; 357 (19): 1946–1955.

    Article  CAS  Google Scholar 

  31. Aly H . Mechanical ventilation and cerebral palsy. Pediatrics 2005; 115: 1765–1767.

    Article  Google Scholar 

  32. Bhuta T, Ohlsson A . Systemic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1998; 79: F26–F33.

    Article  CAS  Google Scholar 

  33. Arias-Camison JM, Lau J, Cole CH, Frantz III ID . Meta-analysis of dexamethasone therapy started in first 15 h of life for prevention of chronic lung disease in premature infants. Pediatr Pulmonol 1999; 28: 167–174.

    Article  CAS  Google Scholar 

  34. Doyle L, Davis P . Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function. J Pediatr Child Health 2000; 36: 101–107.

    Article  CAS  Google Scholar 

  35. Lee BH, Stoll BJ, McDonald SA, Higgins RD, for National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone. Pediatrics 2008; 121 (2): 289–296.

    Article  Google Scholar 

  36. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O et al. Neurotoxicity of glucocorticoids in primate brain. Horm Behav 1994; 28: 336–348.

    Article  CAS  Google Scholar 

  37. Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Recker EB et al. Brain damage induced by prenatal exposure of dexamethasone in fetus rhesus macaques: I. Hippocampus. Dev Brain Res 1990; 53: 157–167.

    Article  CAS  Google Scholar 

  38. Doyle LW, Gavis PG, Morley CJ, McPhee A, Carlin JB, and the DART Study Investigators. Pediatr 2006; 117 (1): 75–83.

    Article  Google Scholar 

  39. Doyle LW, Gavis PG, Morley CJ, McPhee A, Carlin JB, and the DART Study Investigators. Pediatr 2007; 119 (4): 716–721.

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge the hard work and dedication of the many health-care providers involved in the provision of a high level of intensive care to the many patients we serve at our center.

Author information

Authors and Affiliations

  1. Division of Newborn Medicine, Department of Pediatrics, Regional Neonatal Center, Maria Fareri Children's Hospital at Westchester Medical Center, New York Medical College, Valhalla, NY, USA

    M DeCastro, L Parton, P Ballabh & E F LaGamma

  2. Department of Pediatrics, SUNY Downstate Medical Center, Brooklyn, NY, USA

    N El-Khoury

Authors
  1. M DeCastro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N El-Khoury
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Parton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Ballabh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E F LaGamma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to P Ballabh or E F LaGamma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeCastro, M., El-Khoury, N., Parton, L. et al. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study. J Perinatol 29, 297–304 (2009). https://doi.org/10.1038/jp.2008.194

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2008.194

Keywords

This article is cited by

Search

Advanced search

Quick links